颈动脉斑块炎症PET显像与5年复发性卒中预测
该研究汇总3项前瞻性研究个体数据,纳入近期非严重缺血性卒中/TIA且同侧颈动脉狭窄50%-99%的患者,评估18FDG-PET显示的斑块炎症与5年复发性同侧缺血性卒中的关联。结果显示斑块SUVmax和SCAIL评分均独立预测5年复发卒中,提示斑块炎症显像有助于识别可从血运重建中获益的患者。
要点
- 颈动脉斑块18FDG摄取越高,5年同侧缺血性卒中复发风险越高。
- SCAIL评分每增加1分,5年同侧卒中风险增加,校正后HR 2.73。
- 斑块炎症显像可能优化颈动脉血运重建的患者选择。
核心结论
- 颈动脉斑块炎症相关的18FDG摄取可改善对5年复发性同侧缺血性卒中的识别。
研究设计与样本
- 对3项方法近乎相同的前瞻性研究进行个体参与者数据汇总分析。
- 纳入近期非严重缺血性卒中/TIA且同侧颈动脉狭窄50%-99%的患者,共183例符合条件,181例完成随访。
- 招募后≤14天行颈动脉18FDG-PET/CT血管成像,随访中位4.9年。
主要发现
- PET显像后5年内17例发生复发性同侧缺血性卒中,复发率9.4%(95%CI 5.6%-14.6%)。
- 基线斑块SUVmax每增加1-g/mL,校正后5年同侧复发卒中HR 1.98(95%CI 1.10-3.56,p=0.02)。
- SCAIL评分每增加1分,校正后5年同侧卒中HR 2.73(95%CI 1.52-4.90,p=0.001)。
关键数值与推荐
- SUVmax取自症状性斑块轴向最热单层切片。
- SCAIL评分整合狭窄严重程度与18FDG摄取。
- 主要结局为PET显像后5年复发性同侧缺血性卒中。
临床怎么用
- 对近期缺血性卒中/TIA合并同侧颈动脉狭窄患者,可考虑斑块炎症PET显像辅助评估晚期复发风险。
- 斑块炎症信息结合现有选择策略,可能有助于筛选最可能从血运重建中获益的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: To determine whether carotid plaque inflammation identified by 18F-fluorodeoxyglucose (18FDG)-PET is associated with late (5-year) recurrent stroke. METHODS: We did an individual-participant data pooled analysis of 3 prospective studies with near-identical study methods. Eligible patients had recent nonsevere (modified Rankin Scale score ≤3) ischemic stroke/TIA and ipsilateral carotid stenosis (50%-99%). Participants underwent carotid 18FDG-PET/CT angiography ≤14 days after recruitment. 18FDG uptake was expressed as maximum standardized uptake value (SUVmax) in the axial single hottest slice of symptomatic plaque. We calculated the previously validated Symptomatic Carotid Atheroma Inflammation Lumen-Stenosis (SCAIL) score, which incorporates a measure of stenosis severity and 18FDG uptake. The primary outcome was 5-year recurrent ipsilateral ischemic stroke after PET imaging. RESULTS: Of 183 eligible patients, 181 patients completed follow-up (98.9%). The median duration of follow-up was 4.9 years (interquartile range 3.3-6.4 years, cumulative follow-up period 901.8 patient-years). After PET imaging, 17 patients had a recurrent ipsilateral ischemic strokes at 5 years (recurrence rate 9.4%, 95% confidence interval [CI] 5.6%-14.6%). Baseline plaque SUVmax independently predicted 5-year ipsilateral recurrent stroke after adjustment for age, sex, carotid revascularization, stenosis severity, NIH Stroke Scale score, and diabetes mellitus (adjusted hazard ratio [HR] 1.98, 95% CI 1.10-3.56, p = 0.02 per 1-g/mL increase in SUVmax). On multivariable Cox regression, SCAIL score predicted 5-year ipsilateral stroke (adjusted HR 2.73 per 1-point increase, 95% CI 1.52-4.90, p = 0.001). DISCUSSION: Plaque inflammation-related 18FDG uptake improved identification of 5-year recurrent ipsilateral ischemic stroke. Addition of plaque inflammation to current selection strategies may target patients most likely to have late and early benefit from carotid revascularization. CLASSIFICATION OF EVIDENCE: This study provides Class I evidence that in individuals with recent ischemic stroke/TIA and ipsilateral carotid stenosis, carotid plaque inflammation-related 18FDG uptake on PET/CT angiography was associated with 5-year recurrent ipsilateral stroke.
引用
- McCabe JJ, Camps-Renom P, Giannotti N, et al. Carotid Plaque Inflammation Imaged by PET and Prediction of Recurrent Stroke at 5 Years. Neurology. 2021. PMID: 34610991. doi:10.1212/WNL.0000000000012909
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。